North Media A/S
Company announcement No 04-2021
12 February 2021
Pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them must notify the Danish Financial Supervisory Authority and notify North Media A/S of transactions related to shares in North Media A/S.
North Media A/S hereby makes public pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse the following information received from persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them (see attached).
The transactions are:
Name | Holdings before transaction, no. of shares | Transaction, no. of shares | Holdings after transaction, no. of shares |
Mads Dahl Møberg Andersen (acquisition) | 170,385 | 3,000 | 173,385 |
For further information
Kåre Wigh, Group Executive Director & CFO, mobile +45 25 65 21 45
This document is an unofficial translation of the Danish original. In the event of any inconsistencies, the Danish version shall apply.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
FLSmidth A/S9.7.2025 08:41:33 CEST | Press release
Correction to Company Announcement no. 15-2025: Transactions under share buy-back programme
Syensqo SA9.7.2025 08:30:00 CEST | Press release
Syensqo - Participation notification by BlackRock Inc.
Sparekassen Sjælland-Fyn A/S9.7.2025 08:13:26 CEST | Pressemeddelelse
SJF Bank opjusterer forventningerne til resultatet for 2025
Ekopak N.V.9.7.2025 08:10:24 CEST | Press release
Ekopak appoints Jean-Baptiste De Cuyper as new CEO
Purespring Therapeutics9.7.2025 08:00:00 CEST | Press release
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom